Research
Hormonal
Testosterone replacement therapy (TR) increased pubic hair in 72.7% of adult male patients with Prader-Willi syndrome.
Practitioners may consider TR as a viable option to enhance secondary sexual characteristics in this population.
StrongSupportsmedium confidence
Increased pubic hair was observed in 16 of 22 patients (72.7%).
Why this rating
Based on the observational study design with a defined patient population.
Source
Testosterone replacement therapy to improve secondary sexual characteristics and body composition without adverse behavioral problems in adult male patients with Prader–Willi syndrome: An observational study
Yasuhiro Kido et al. · American Journal of Medical Genetics Part A · 2013
DOI 10.1002/ajmg.a.36048
cohort · n=22Cited 41×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →